ASX - By Stock
|
IMM |
Re:
Media
|
|
Launic
|
737 |
323K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
737
|
323K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Interesting article in Saturday Telegraph relating to Keytruda.
|
|
Launic
|
13 |
7.2K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
13
|
7.2K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics Corporate Presentation
|
|
Launic
|
82 |
23K |
0 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
82
|
23K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Dosing commenced in the ATL1102 toxicology study
|
|
Launic
|
19 |
7.1K |
4 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
19
|
7.1K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
|
|
Launic
|
70 |
28K |
2 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
70
|
28K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Launic
|
382 |
191K |
0 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
382
|
191K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Launic
|
2.6K |
1.0M |
15 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
15
|
|